; and (B) other personnel needed during the COVID–19 pandemic; (2) challenges associated with the hiring, recruitment, and retention of the Federal, State, local, Tribal, and territorial public health workforce; and (3) recommended steps the Federal Government should take to improve hiring, recruitment, and retention of the public health workforce. (c) Report Not later than December 1, 2021, the Comptroller General shall submit to the Congress a report on the findings of the study conducted under this section. 30617. Longitudinal study on the impact of COVID–19 on recovered patients Part A of title IV of the Public Health Service Act ( 42 U.S.C. 281 et seq.) is amended by adding at the end the following: 404O. Longitudinal study on the impact of COVID–19 on recovered patients (a) In general The Director of NIH, in consultation with the Director of the Centers for Disease Control and Prevention, shall conduct a longitudinal study, over not less than 10 years, on the full impact of SARS–CoV–2 or COVID–19 on infected individuals, including both short-term and long-term health impacts. (b) Timing The Director of NIH shall begin enrolling patients in the study under this section not later than 6 months after the date of enactment of this section. (c) Requirements The study under this section shall— (1) be nationwide; (2) include diversity of enrollees to account for gender, age, race, ethnicity, geography, comorbidities, and underrepresented populations, including pregnant and lactating women; (3) study individuals with COVID–19 who experienced mild symptoms, such individuals who experienced moderate symptoms, and such individuals who experienced severe symptoms; (4) monitor the health outcomes and symptoms of individuals with COVID–19, or who had prenatal exposure to SARS–CoV–2 or COVID–19, including lung capacity and function, and immune response, taking into account any pharmaceutical interventions such individuals may have received